Xie et al. [27], in their analysis, revealed a novel BAP1-MAFF signaling axis that may be fundamental for CRC growth and could be regarded as either a prognostic marker or a potential therapeutic target. This evidence concerns the gene MAFF and colorectal carcinoma.